Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Lung Cancer, Precision Oncology Platform Trials

Vassiliki Papadimitrakopoulou

MD

🏢MD Anderson Cancer Center🌐USA

Professor of Medicine

55
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Vassiliki Papadimitrakopoulou at MD Anderson helped design and lead the BATTLE-2 precision oncology platform trial in lung cancer — one of the first biomarker-stratified adaptive trials in thoracic oncology. Her extensive contributions to NSCLC clinical trial development, lung cancer biomarker-driven therapy, and adaptive precision oncology platform trial methodology have advanced the integration of molecular profiling into lung cancer clinical trials.

Share:

🧪Research Fields 研究领域

lung cancer
BATTLE-2 trial
adaptive precision oncology
KRAS lung cancer
biomarker-driven lung trials

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-02-01 | All information from publicly available academic sources

关注 Vassiliki Papadimitrakopoulou 的研究动态

Follow Vassiliki Papadimitrakopoulou's research updates

留下邮箱,当我们发布与 Vassiliki Papadimitrakopoulou(MD Anderson Cancer Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment